The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2026

Filed:

Aug. 14, 2019
Applicant:

Sonivie Ltd., Rosh HaAyin, IL;

Inventors:

Ariel Sverdlik, Tel-Aviv, IL;

Or Shabtay, Kibbutz Farod, IL;

Lilah Marziano, Ganei-Tikva, IL;

Assignee:

SONIVIE LTD., Rosh Haayin, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 7/02 (2006.01); A61B 18/00 (2006.01); A61N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61N 7/02 (2013.01); A61N 7/00 (2013.01); A61N 7/022 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00255 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00351 (2013.01); A61B 2018/00375 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00541 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/00708 (2013.01); A61B 2018/00732 (2013.01); A61B 2018/00761 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00863 (2013.01); A61N 2007/003 (2013.01); A61N 2007/0043 (2013.01); A61N 2007/0052 (2013.01); A61N 2007/0078 (2013.01);
Abstract

The present invention in some embodiments thereof relates to a method for selectively modifying nerve activity without causing substantial damage to non-targeted tissue, comprising introducing a catheter device comprising one or more ultrasonic transceivers to the pulmonary artery lumen, receiving, using the one or more ultrasonic transceivers, echo signals reflected from the non-targeted tissue following emission of ultrasound energy by the one or more transceivers, analyzing the received echo signals to identify at least one of a type and location of the non-targeted tissue relative to the one or more transceivers, and emitting ultrasound energy from the one or more ultrasonic transceivers in accordance with the analysis, to modify nerve activity without substantially damaging the identified non-targeted tissue.


Find Patent Forward Citations

Loading…